Xun Xu Selected Research

Inflammation (Inflammations)

1/2021	Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas.
1/2021	Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System.
12/2019	KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis.
1/2018	PAPep Inhibits Secretion of Poly(I:C)-Induced Inflammatory Cytokines and ICAM-1 Expression in Corneal Fibroblasts by Suppressing the NF-κB/p38 Pathway.
1/2018	Effect of Celecoxib on Surgical Site Inflammation after Total Knee Arthroplasty: A Randomized Controlled Study.
1/2018	Sex Differences in Genetic Associations With Longevity.
11/2017	Peptide GC31 inhibits chemokines and ICAM-1 expression in corneal fibroblasts exposed to LPS or poly(I:C) by blocking the NF-κB and MAPK pathways.
2/2017	Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
6/2016	The role of N-glycosylation in high glucose-induced upregulation of intercellular adhesion molecule-1 on bovine retinal endothelial cells.
2/2016	Novel loci and pathways significantly associated with longevity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xun Xu Research Topics

Disease

46	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2021 - 12/2002
33	Neoplasms (Cancer) 11/2022 - 02/2009
21	Inflammation (Inflammations) 01/2021 - 09/2004
19	Infections 01/2022 - 05/2002
14	Myopia 11/2022 - 07/2011
12	Ganglion Cysts (Ganglion) 01/2022 - 05/2003
12	Macular Edema 01/2020 - 11/2009
12	Retinal Detachment (Retinal Detachments) 04/2019 - 05/2003
10	Macular Degeneration (Age-Related Maculopathy) 06/2022 - 12/2002
9	Refractive Errors (Refractive Error) 05/2022 - 01/2006
9	Virus Diseases (Viral Diseases) 06/2021 - 01/2005
8	Type 2 Diabetes Mellitus (MODY) 08/2021 - 03/2010
8	Retinal Neovascularization 01/2021 - 06/2008
8	Choroidal Neovascularization 01/2020 - 10/2008
8	Hyperglycemia 02/2017 - 05/2008
8	Corneal Neovascularization 01/2017 - 02/2007
7	Cataract (Cataracts) 08/2021 - 12/2002
7	Glaucoma 04/2021 - 10/2011
7	Uveitis 12/2019 - 01/2011
6	Retinal Perforations 04/2022 - 08/2011
6	COVID-19 01/2022 - 01/2020
6	Pathologic Neovascularization 12/2020 - 11/2009
5	Retinal Vein Occlusion 01/2022 - 10/2013
5	Hemorrhage 01/2020 - 08/2008
5	Burns 03/2018 - 05/2010
5	Vitreous Detachment (Posterior Vitreous Detachment) 01/2012 - 09/2004
5	Leukemia 06/2011 - 10/2009
4	Atrophy 06/2022 - 01/2021
4	Ischemia 01/2021 - 05/2014
4	Neoplasm Metastasis (Metastasis) 03/2020 - 06/2010
4	Hypoxia (Hypoxemia) 01/2020 - 07/2010
3	Astigmatism 01/2022 - 03/2013
3	Cytokine Release Syndrome 01/2022 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2013
3	Disease Resistance 10/2019 - 12/2017
3	Retinal Diseases 01/2019 - 01/2012
3	Epiretinal Membrane (Epiretinal Membranes) 01/2019 - 11/2006
3	Keratitis 11/2017 - 12/2015
3	Neovascular Glaucoma 06/2016 - 01/2016
3	Deafness (Deaf Mutism) 04/2015 - 12/2014
3	Blindness (Hysterical Blindness) 01/2015 - 12/2002

Drug/Important Bio-Agent (IBA)

54	Retinaldehyde (Retinal)IBA 01/2022 - 12/2002
29	Peptides (Polypeptides)IBA 01/2021 - 02/2007
26	Proteins (Proteins, Gene)FDA Link 08/2021 - 05/2002
26	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 04/2004
14	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2006
10	Pharmaceutical PreparationsIBA 01/2021 - 10/2008
10	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2017 - 02/2006
9	Ranibizumab (Lucentis)FDA Link 01/2022 - 08/2012
9	Messenger RNA (mRNA)IBA 05/2019 - 03/2007
9	Bevacizumab (Avastin)FDA Link 01/2019 - 10/2008
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2013
7	Oxygen (Dioxygen)IBA 01/2021 - 06/2011
7	CytokinesIBA 01/2020 - 08/2008
7	EnzymesIBA 01/2020 - 07/2010
6	Mydriatics (Cycloplegics)IBA 11/2022 - 01/2017
6	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2014
6	KH902 fusion proteinIBA 01/2020 - 09/2014
6	AlkaliesIBA 03/2018 - 05/2010
6	EndotoxinsIBA 05/2014 - 01/2011
5	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2005
5	Phosphotransferases (Kinase)IBA 01/2020 - 10/2011
4	NucleotidesIBA 05/2022 - 03/2012
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
4	Transcription Factors (Transcription Factor)IBA 06/2018 - 07/2010
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017 - 01/2011
4	Hyaluronic Acid (Hyaluronan)IBA 07/2015 - 09/2007
4	Small Interfering RNA (siRNA)IBA 01/2012 - 04/2010
4	AntigensIBA 11/2010 - 10/2009
3	Biological ProductsIBA 01/2022 - 01/2012
3	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2009
3	InterleukinsIBA 01/2022 - 01/2011
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2021 - 11/2020
3	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 06/2009
3	Tryptophan (L-Tryptophan)FDA Link 11/2020 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2011
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020 - 01/2017
3	Capsules (Microcapsules)IBA 01/2019 - 02/2016
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2019 - 10/2012
3	ThrombomodulinIBA 11/2017 - 11/2011
3	Neuroprotective AgentsIBA 09/2017 - 08/2014
3	Therapeutic UsesIBA 01/2017 - 08/2012
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2015 - 02/2013
3	pigment epithelium-derived factorIBA 01/2014 - 04/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012 - 04/2007

Therapy/Procedure

26	Therapeutics 11/2022 - 07/2008
11	Intravitreal Injections 01/2021 - 01/2005
11	Lasers (Laser) 01/2020 - 11/2009
7	Vitrectomy 04/2022 - 11/2009
6	Drug Therapy (Chemotherapy) 01/2021 - 06/2009
6	Aftercare (After-Treatment) 05/2019 - 07/2011
5	Light Coagulation 01/2020 - 11/2009
5	Injections 01/2017 - 01/2014
4	Telescopes 05/2022 - 11/2006
4	Immunotherapy 01/2022 - 10/2010
4	Transplantation 07/2021 - 10/2012
3	Traction 06/2022 - 08/2011
3	Slit Lamp 03/2010 - 01/2006